A disintegrin and metalloprotease 10 (ADAM10) is essential for embryonic development and 2 impacts on diseases such as cancer, Alzheimer's and inflammatory diseases. ADAM10 is a 3 'molecular scissor' that proteolytically cleaves the extracellular region from over 100 substrates, 4 including Notch, amyloid precursor protein, cadherins, growth factors and chemokines. 5 ADAM10 was recently proposed to function as six distinct scissors with different substrates, 6 depending on its association with one of six regulatory tetraspanins, termed TspanC8s. 7 However, it remains unclear to what degree ADAM10 function is critically dependent on a 8 TspanC8 partner. To address this, we generated the first monoclonal antibodies to Tspan15 as a 9 model TspanC8. These were used to show that ADAM10 is the principal Tspan15-interacting 10 protein, that Tspan15 expression requires ADAM10 in cell lines and primary cells, and that a 11 synthetic ADAM10/Tspan15 fusion protein is a functional scissor. Together these findings 12 suggest that ADAM10 exists as an intimate ADAM10/TspanC8 scissor complex. 13 14 15
Introduction
The first crystal structure of a tetraspanin suggests the capacity for conformational change, The four Tspan15 mAbs bind to similar epitopes in the large extracellular loop 102 To determine whether the Tspan15 mAbs have epitopes in the large extracellular loop (LEL), 103 previously described Tspan15/Tspan5 chimeric GFP-tagged constructs were used in which the 104 LELs were exchanged (Saint-Pol et al. 2017) . In flow cytometry analyses of transfected HEK- 105 293T cells, the four Tspan15 mAbs detected the Tspan15 LEL on a Tspan5 backbone (T5-106 LEL15), but not the reciprocal protein (T15-LEL5) (Figure 2A ). As a control, a Tspan5 mAb 107 detected Tspan5 LEL on a Tspan15 backbone (Figure 2A that reactivity of all four Tspan15 mAbs was almost completely lost by changing residues FSV 123 to LNA, but unaffected in the three other chimeras ( Figure 2D ). However, the human FSV 124 sequence was not sufficient for recognition, because introduction of these residues into mouse 125 Tspan15 did not enable recognition by the four Tspan15 mAbs ( Figure 2E ). Taken together, 126 these data show that all four Tspan15 mAbs bind to similar epitopes within the LEL. and reciprocal chimera (data not shown). 153   The generation of Tspan15 mAbs enabled the first proteomic identification of interactors with   154   endogenous Tspan15. To do this, Tspan15 mAb 1C12 was used to immunoprecipitate Tspan15   155   from wild-type HEK-293T cells lysed in the relatively stringent detergent 1% digitonin;   156 Tspan15-knockout cells were used as a negative control. Subsequent mass spectrometry 157 identification revealed 28 proteins that were significantly detected in wild-type versus Tspan15-158 knockout samples from five independent experiments (Table 1 and Supplementary Table 1 ). 159 Expression of the entire dataset as a volcano plot illustrated how the most significant and 160 differential protein identified was ADAM10 ( Figure 3 ). Indeed, ADAM10 and Tspan15 were 161 the only proteins above the false discovery threshold for these experiments (Figure 3 ). These 162 data suggest that ADAM10 is the principal Tspan15-interacting protein in HEK-293T cells. 
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ADAM10 is the principal Tspan15-interacting protein
Tspan15 protein expression requires ADAM10
It is well established that TspanC8s promote the enzymatic maturation and trafficking of Tspan15 expression was comparable in wild-type versus ADAM10-knockout cells ( Figure 4E ). 214 Therefore, it appears that endogenous Tspan15 protein expression requires ADAM10, but over-215 expressed Tspan15 can bypass this requirement. The requirement of Tspan15 for ADAM10 surface expression is cell type dependent 243 To assess the extent to which Tspan15 is required for ADAM10 surface expression in the cells 244 examined in Figure 4 , flow cytometry for ADAM10 was performed. ADAM10 surface 245 expression was reduced by approximately 60% and 70% in Tspan15-knockout HEK-293T and 246 A549 cells, respectively, but was unaffected in Jurkat T cells ( Figure 5A ). In HUVECs, 247 ADAM10 surface expression was reduced by approximately 40% following Tspan15 siRNA 248 knockdown ( Figure 5B ). Therefore, the importance of Tspan15 for ADAM10 surface expression 249 depends on the cell type. unclear why this is the case, but it is possible that Tspan15 protein expression is low in these 383 cells, relative to other tetraspanins. 384 The previously discussed finding that Tspan15 expression requires ADAM10 suggests that the 385 two proteins might exist as a functional complex. A prediction of this idea is that physically 386 linking the two proteins into a single fusion protein would yield a functional scissor protein. 387 Indeed, we found that an ADAM10/Tspan15 fusion protein was expressed at the cell surface at 388 the predicted molecular weight, and was functional in a betacellulin shedding assay in a manner 389 that was comparable to when the two proteins were expressed individually. In this shedding interpretation was complicated in these two studies because of the use of less stringent detergent 432 and the resulting large number of tetraspanin-associated proteins identified, the majority of 433 which are likely to be indirectly associated with Tspan15. In our study ,in addition to ADAM10, 434 26 proteins were identified as being significantly more detected in wild-type versus Tspan15-435 knockout samples, but the most differential of these was only four-fold higher in wild-type. 436 Thus, it remains to be determined whether any of these are definitive ADAM10/Tspan15- 437 interacting proteins that impact functionally on the complex. Of note, we did not identify beta- To conclude, our findings strongly suggest that Tspan15 exists as an ADAM10/Tspan15 scissor 471 complex, which may be a general theme for the other five TspanC8s. We therefore propose that 472 ADAM10 be studied in the context of its associated TspanC8. This has implications for future 473 work that should aim to determine how ADAM10/TspanC8 complexes are triggered to cleave 474 specific substrates, and whether ADAM10/TspanC8 complexes can be therapeutically targeted to 475 treat human disease. 
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MATERIALS AND METHODS
